M. Nenni Et Al. , "Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies," Current Traditional Medicine , vol.6, 2020
Nenni, M. Et Al. 2020. Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies. Current Traditional Medicine , vol.6 .
Nenni, M., Öncül, S., Ercan, A., Çelebier, M., Süslü, İ., & Haznedaroğlu, İ. C., (2020). Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies. Current Traditional Medicine , vol.6.
Nenni, MERVE Et Al. "Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies," Current Traditional Medicine , vol.6, 2020
Nenni, MERVE Et Al. "Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies." Current Traditional Medicine , vol.6, 2020
Nenni, M. Et Al. (2020) . "Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies." Current Traditional Medicine , vol.6.
@article{article, author={MERVE NENNİ Et Al. }, title={Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper® Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies}, journal={Current Traditional Medicine}, year=2020}